Unichem Laboratories

Unichem Laboratories Current Liabilities

The Current Liabilities of Unichem Laboratories (UNICHEMLAB.NS) as of Oct 29, 2026 is 3.92 B INR. In the previous year, Current Liabilities was 2.08 B INR — a change of 88.56% (higher).

Current Liabilities

3.92 BINR

YoY

88.56%

Last updated:

Current Liabilities of Unichem Laboratories is 2025 3.92 B INR. Current Liabilities of Unichem Laboratories was 2024 2.08 B INR. It decreases by 88.56% higher compared to the previous year.

The Unichem Laboratories Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
4.31 B INR
Jan 1, 2019
4.55 B INR
Jan 1, 2020
5.16 B INR
Jan 1, 2021
1.21 B INR
Jan 1, 2022
2.64 B INR
Jan 1, 2023
2.73 B INR
Jan 1, 2024
2.08 B INR
Jan 1, 2025
3.92 B INR
The Unichem Laboratories Current Liabilities history
YEARCurrent LiabilitiesYoY
3.92 BINR+88.56%
2.08 BINR-23.89%
2.73 BINR+3.42%
2.64 BINR+117.86%
1.21 BINR-76.53%
5.16 BINR+13.51%
4.55 BINR+5.52%
4.31 BINR+14.00%
3.78 BINR+60.69%
2.35 BINR+4.35%
2.25 BINR-8.59%
2.47 BINR-1.82%
2.51 BINR+7.68%
2.33 BINR+32.42%
1.76 BINR+6.47%
1.65 BINR+13.06%
1.46 BINR+8.53%
1.35 BINR+8.89%
1.24 BINR+13.89%
1.09 BINR-20.01%
1.36 BINR+43.51%
947.00 MINR+33.19%
711.00 MINR+63.07%
436.00 MINR+20.11%
363.00 MINR+20.60%
301.00 MINR+20.88%
249.00 MINR+0.40%
248.00 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Unichem Laboratories Stock analysis

What does Unichem Laboratories do? Unichem Laboratories Ltd. generates revenue through the manufacturing and marketing of pharmaceutical formulations, including branded generics and generics across global markets. The company develops and produces complex active pharmaceutical ingredients (API) and dosage forms, targeting therapeutic areas such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives, and pain management. Its subsidiaries, Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta, and Niche Generics Limited UK, support its international operations. Contract manufacturing services for immediate-release and extended-release dosage forms, dry powder injections, syrups, and novel drug delivery systems also contribute to its revenue streams. The company sells its products to healthcare providers, hospitals, and pharmacies worldwide, leveraging its focus on product development and process chemistry. Unichem Pharmaceuticals (USA) Inc and Unichem Farmaceutica Do Brasil Lta serve as key regional entities for market expansion, while Niche Generics Limited UK facilitates operations in the European market. The firm's portfolio includes both branded generics and generic formulations, catering to diverse therapeutic needs across multiple geographies. Unichem Laboratories Ltd. emphasizes technology transfer and documentation in its contract manufacturing services, which are sought by partners in the pharmaceutical industry. The company's product range addresses critical healthcare segments, ensuring consistent demand for its formulations. Its global presence, supported by subsidiaries in the USA, Brazil, and the UK, enables it to serve international clients effectively. Unichem Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Unichem Laboratories stock

Current Liabilities of Unichem Laboratories is 3.92 B INR in 2025.

Current Liabilities of Unichem Laboratories changed from 2.08 B INR to 3.92 B INR, representing a 88.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Unichem Laboratories since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Unichem Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Unichem Laboratories

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Unichem Laboratories